You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 10,786,662


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,786,662
Title:Method of manufacturing microneedle and microneedle manufactured thereby
Abstract: A method of manufacturing a microneedle according to the present disclosure includes a step of preparing a microneedle; a step of cooling the microneedle; and a step of inducing an endothermic reaction of the cooled microneedle, and coating the cooled microneedle with an active ingredient at least once. In accordance with such a configuration, coatability of the active ingredient can be improved due to an endothermic reaction without a separate drying process, thereby providing superior medication.
Inventor(s): Baek; Seung Ki (Seoul, KR), Ahn; Myun Hwan (Namyangju-si, KR), Baek; Sun Young (Seoul, KR)
Assignee: QuadMedicine (Seongnam-si, KR)
Application Number:15/863,318
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding and Analyzing Patent Claims: A Comprehensive Guide Using the Example of US Patent 10,786,662

Introduction

Patent claims are the heart of any patent application, defining the scope of the invention and the rights granted to the patent holder. Analyzing these claims is crucial for understanding the patent landscape, especially in the context of U.S. patent law. This article will delve into the intricacies of patent claims, using US Patent 10,786,662 as an example, and explore the broader patent landscape in the United States.

What are Patent Claims?

Patent claims are the specific statements in a patent application that define the invention for which protection is sought. These claims must be clear, concise, and supported by the description and drawings in the patent specification[1].

Determining Inventorship

Before diving into the claims themselves, it is essential to understand who is considered an inventor. In U.S. patent law, an inventor is someone who conceives the subject matter of at least one claim of the patent. This conception must be a "definite and permanent idea of the complete and operative invention" that can be reduced to practice without extensive research or experimentation[1].

The Structure of Patent Claims

Patent claims can be independent or dependent. Independent claims stand alone and define the invention without reference to other claims. Dependent claims, on the other hand, refer back to and further limit an independent claim or another dependent claim[2].

Analyzing the Claims of US Patent 10,786,662

To analyze the claims of a specific patent like US Patent 10,786,662, one must start by identifying the independent claims, as these define the broadest scope of the invention. Here are some key steps:

Identifying Independent Claims

Independent claims are crucial as they set the broadest boundaries of the invention. For example, if US Patent 10,786,662 has multiple independent claims, each would define a distinct aspect of the invention.

Understanding Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations. These claims help to further define the invention and can be used to differentiate it from prior art.

Claim Construction

Claim construction involves interpreting the meaning of the claims to determine the scope of protection. This process is critical in patent litigation and during the patent examination process. The courts and the Patent Trial and Appeal Board (PTAB) use various rules and precedents to construe claims, ensuring they are consistent with the patent specification and the prosecution history[5].

The Importance of Claim Analysis Tools

Given the complexity and volume of patent claims, automated tools like LexisNexis PatentOptimizer can significantly streamline the analysis process. These tools help in importing, parsing, and compressing claims, making it easier to review and understand the hierarchy of claims. They also assist in ensuring that the claims are broad but defensible, reducing the risk of office actions and rejections[4].

Inter Partes Review (IPR) and Patent Validity

The validity of patent claims can be challenged through Inter Partes Review (IPR), a process established by the America Invents Act (AIA). IPR allows third parties to challenge the validity of issued patents before the PTAB, which can cancel patent claims if they are found to be invalid. This process is often faster and less expensive than litigation in federal court and requires a lower burden of proof[5].

The Role of PTAB

The Patent Trial and Appeal Board (PTAB) plays a crucial role in reviewing patent validity. PTAB hearings involve procedural rules, discovery, affidavits, and oral hearings, similar to court proceedings. However, the question of whether IPR is constitutional has been debated, with some arguing it resembles judicial proceedings too closely[3][5].

Challenges in the Patent Landscape

The patent landscape is increasingly complex due to the rising number of patent applications and claims. From 1963 to 1983, the USPTO received approximately 100,000 patent applications per year, but this number has significantly increased, with over 326,000 applications filed in 2001 alone. This trend is driven by technological innovation and facilitated by advancements in technology that simplify the patent application process[2].

Managing the Volume of Claims

With some patent applications containing hundreds or even thousands of claims, managing and reviewing these claims efficiently is a significant challenge. Automated systems and tools are essential for navigating this complexity and ensuring that claims are thoroughly reviewed and validated[2].

Best Practices for Drafting Patent Claims

Drafting high-quality patent claims is critical for securing robust patent protection. Here are some best practices:

Ensure Clarity and Conciseness

Claims should be clear and concise to avoid ambiguity. This clarity is essential for both the patent examination process and any future litigation.

Use Automated Tools

Tools like LexisNexis PatentOptimizer can help streamline the drafting process, ensure error-free claims, and provide comprehensive error reports to fortify the application before submission to the USPTO[4].

Conduct Thorough Prior Art Search

A thorough prior art search is essential to ensure that the claims are novel and non-obvious. This search can be facilitated by advanced patent search tools like LexisNexis TotalPatent One[4].

Key Takeaways

  • Clear and Concise Claims: Ensure that patent claims are clear, concise, and supported by the patent specification.
  • Automated Tools: Utilize automated tools to streamline the analysis and drafting of patent claims.
  • Inventorship Determination: Accurately determine inventorship to avoid issues with patent validity.
  • IPR and PTAB: Understand the role of IPR and PTAB in challenging and validating patent claims.
  • Best Practices: Follow best practices in drafting patent claims, including thorough prior art searches and using automated tools.

FAQs

What is the significance of independent claims in a patent application?

Independent claims define the broadest scope of the invention and are crucial for understanding the patent's protection boundaries.

How does Inter Partes Review (IPR) impact patent validity?

IPR allows third parties to challenge the validity of issued patents before the PTAB, which can cancel patent claims if found invalid, providing a faster and less expensive alternative to federal court litigation.

What role do automated tools play in patent claim analysis?

Automated tools like LexisNexis PatentOptimizer streamline the analysis and drafting of patent claims, ensuring clarity, conciseness, and reducing the risk of office actions and rejections.

Why is claim construction important?

Claim construction is critical for determining the scope of protection and is used in patent litigation and during the patent examination process to ensure consistency with the patent specification and prosecution history.

How has the volume of patent applications impacted the patent landscape?

The increasing volume of patent applications and claims has made managing and reviewing claims more complex, necessitating the use of automated tools and advanced search technologies.

Sources

  1. Determining Inventorship for US Patent Applications - Oregon State University
  2. US20110138338A1 - Patent Claims Analysis System and Method - Google Patents
  3. Is Inter Partes Review Unconstitutional? - Wyatt, Tarrant & Combs, LLP
  4. PatentOptimizer | LexisNexis Intellectual Property Solutions - LexisNexis
  5. The Patent Trial and Appeal Board and Inter Partes Review - Congressional Research Service

More… ↓

⤷  Subscribe

Details for Patent 10,786,662

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 January 15, 1974 ⤷  Subscribe 2037-01-05
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 December 27, 1984 ⤷  Subscribe 2037-01-05
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 February 15, 1985 ⤷  Subscribe 2037-01-05
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 February 16, 1990 ⤷  Subscribe 2037-01-05
Bel-mar Laboratories, Inc. CHORIONIC GONADOTROPIN chorionic gonadotropin Injection 017054 March 26, 1974 ⤷  Subscribe 2037-01-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.